LPTX Live signaler | Maksimer profitt med Getagraph.com

SELG 120413 min ago

@ $3.52

Utstedt: 8 feb 2024 @ 20:59

Avkastning: -7.10%

Forrige signal: feb 7 - 21:44

Forrige signal: Kjøp

Avkastning: 2.03 %

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 22:00):

Stats
Dagens volum	151 390
Gjennomsnittsvolum	313 747
Markedsverdi	83.72M
EPS	$0 ( 2024-03-22 )
Neste inntjeningsdato	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.820
ATR14	$0.0250 (0.77%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-10	Gilead Sciences, Inc.	Sell	0	Common Stock
2024-01-29	Mashiach Nissim	Buy	25 000	Stock Option (Right to Buy)
2024-01-29	Dietz Thomas John	Buy	30 000	Stock Option (Right to Buy)
2024-01-29	Schilsky Richard	Buy	25 000	Stock Option (Right to Buy)
2024-01-29	Granfield Christine	Buy	85 000	Employee Stock Option (Right to Buy)

INSIDER POWER
66.50
Last 95 transactions
Buy: 10 825 606 \| Sell: 1 768 106

Volum Korrelasjon

Lang: 0.22 (neutral)

Kort: -0.08 (neutral)

Signal:(48.669) Neutral

Leap Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
LPCN	0.922
EWTX	0.919
CNDT	0.917
SRAX	0.915
CPIX	0.911
NESR	0.909
RPAY	0.905
VTRS	0.903
HNNA	0.9
SMSI	0.899

10 Mest negative korrelasjoner
CNCE	-0.851
CNST	-0.84
TYHT	-0.838
UNCY	-0.828
ALR	-0.821
EPZM	-0.819
PSACU	-0.817
BTBD	-0.811
VERX	-0.81
DRNA	-0.809

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Leap Therapeutics Inc Korrelasjon - Valuta/Råvare

-0.29
( neutral )

-0.11
( neutral )

0.00
( neutral )

0.11
( neutral )

-0.77
( moderate negative )

-0.44
( neutral )

Leap Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-427 000 (0.00 %)
EPS:	$-3.98

FY	2023
Omsetning:	$0
Bruttogevinst:	$-427 000 (0.00 %)
EPS:	$-3.98

FY	2022
Omsetning:	$0
Bruttogevinst:	$-415 000 (0.00 %)
EPS:	$-4.82

FY	2021
Omsetning:	$1.50M
Bruttogevinst:	$1.50M (100.00 %)
EPS:	$-0.470

Financial Reports:

No articles found.

Leap Therapeutics Inc

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.